Highlights
NASDAQ: DNLI       Denali Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
41.14   +0.22 (0.54%)  39.09 - 41.37  360,700

Overview

 
Avg Volume (4 weeks):517,220
4 Weeks Range:34.52 - 45.82
4 Weeks Price Volatility (%):
58.58%
52 Weeks Range:12.39 - 45.82
52 Weeks Price Volatility (%):
86.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Denali Therapeutics Inc is a biotechnology company which is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include LRRK2 Inhibitor Program which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle) and others.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4328  4069  664  210 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 43.17+4.20 
 SCKT 2.55+1.09 
 GE 7.63-0.09 
 INTC 48.20-5.70 
 AAL 12.60-0.55 
 MRIN 3.45+1.33 
 AAPL 115.04-0.71 
 OAS 0.155-0.014 
 F 8.16-0.05 
 NIO 27.16-0.22